Micro Ribonucleic acids (microRNAs or miRNAs) have gained attention in the research community in the last decade due to their roles in genetics and cancer biology. Initially, when compared to other nucleic acids their roles were considered insignificant. An extensive study conducted recently on miRNAs has provided a wealth of knowledge regarding the background functions of microRNAs, most importantly, their role in the pathophysiology of diseases such as cancer, gene expression or silencing, protein-coding gene modulation, cell differentiation, proliferation, and death. There has been significant progress made in the identification of the origin of miRNAs which has given researchers and scientists in Nigeria, Africa and the world at large, the privy to focus on their diagnostic potential usage in both clinical fields for investigating the pathological mechanism of diseases and also in the field of research, thus, creating the opportunity to use miRNAs as a predictive non-invasive biomarker in different disease conditions such as Prostrate cancer, Cervical cancer, Esophageal squamous cell carcinoma, Ovarian Cancer, Breast Cancer, Lung cancer, etc., and thus a potential target in therapeutic inventions for this disease conditions in developing parts of the world, in like countries like Nigeria, where the prevalence of these diseases are increasing. Nonetheless, issues such as the standardisation of miRNA quantity, the normal range of miRNA value within the plasma, and the unification of diagnostic techniques for miRNA quantification continue to be debated among various scientific schools of thought; however, its diagnostic importance continues to outweigh the challenges of this new era diagnostic markers.